AstraZeneca (AZNCF) News Today $164.68 +2.12 (+1.30%) As of 10/2/2025 03:30 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartDividendFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock AZNCF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period AstraZeneca (OTCMKTS:AZNCF) Trading 1.3% Higher - What's Next?October 3 at 2:36 AM | americanbankingnews.comAstraZeneca’s US listing to leave £200mn UK stamp duty holeOctober 2 at 8:02 PM | ft.comAstraZeneca (AZN) Jumps to All-Time High on Trump Drug Tariff DelayOctober 2 at 4:17 AM | msn.comStock Movers: AstraZeneca, Puma, GreggsOctober 1 at 1:14 PM | bloomberg.comAstraZeneca climbs Wednesday, outperforms marketOctober 1 at 1:14 PM | marketwatch.comAnalysis-AstraZeneca's US listing may pull other firms from London in its wakeSeptember 30 at 9:58 PM | finance.yahoo.comAstraZeneca Plans Full US Listing While Defusing Fears of UK ExitSeptember 30 at 2:12 AM | money.usnews.comAstraZeneca plans direct US listingSeptember 30 at 2:12 AM | finance.yahoo.comAstraZeneca stokes fears of London exit with New York listingSeptember 29, 2025 | finance.yahoo.comAstraZeneca plans overhaul of US listing to attract more investorsSeptember 29, 2025 | ft.comAstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technologySeptember 26, 2025 | reuters.comAstraZeneca launches DTC platform amid US pricing pressuresSeptember 26, 2025 | finance.yahoo.comAstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditionsSeptember 26, 2025 | finance.yahoo.comAstraZeneca asks Supreme Court to hear lawsuit challenging Medicare drug price negotiationSeptember 25, 2025 | msn.comSet to go up 57%? Here are the latest share price forecasts for AstraZenecaSeptember 25, 2025 | uk.finance.yahoo.comAstraZeneca and Daiichi's breast cancer drug wins US priority reviewSeptember 24, 2025 | lse.co.ukAstraZeneca Wins European Committee's Positive Opinion for Two Drugs Tackling Chronic, Rare DiseasesSeptember 22, 2025 | uk.finance.yahoo.comAstraZeneca PLC ADR rises Monday, outperforms marketSeptember 22, 2025 | marketwatch.comSir Ed Davey blames Trump for AstraZeneca moveSeptember 19, 2025 | msn.comAstraZeneca says Ultomiris shows 3 years relapse-free in NMOSDSeptember 19, 2025 | lse.co.ukAstraZeneca reports Saphnelo demonstrates reduction in disease activitySeptember 19, 2025 | msn.comAstraZeneca’s Saphnelo SC shows reduction in disease activity in SLE trialSeptember 18, 2025 | finance.yahoo.comAssessing AstraZeneca Shares After Investment Pause in Britain and Recent Price SlideSeptember 17, 2025 | finance.yahoo.comAstraZeneca says Fasenra misses main goal in COPD trialSeptember 17, 2025 | finance.yahoo.comAstraZeneca's asthma drug fails 'smoker's lung' studySeptember 17, 2025 | msn.comAstraZeneca, Strong Sterling Drag FTSE 100 Lower Ahead of Key Central Bank DecisionsSeptember 15, 2025 | money.usnews.comAstraZeneca pauses £200mn Cambridge investment amid UK pharma uncertaintySeptember 12, 2025 | msn.comExclusive-AstraZeneca pauses $270 million investment in BritainSeptember 12, 2025 | msn.comAstraZeneca Pauses £200 Million Investment in UK HeadquartersSeptember 12, 2025 | bloomberg.comAstraZeneca pauses £200m Cambridge expansion amid NHS pricing rowSeptember 12, 2025 | finance.yahoo.comAstraZeneca pauses £200m Cambridge investmentSeptember 12, 2025 | bbc.co.ukAstraZeneca (LSE:AZN) Announces Positive Phase III Trial Results For Lung Cancer TreatmentSeptember 8, 2025 | finance.yahoo.comAstraZeneca says Tagrisso and chemotherapy deliver survival benefitsSeptember 7, 2025 | lse.co.ukAstraZeneca's lung cancer combination boosted survival in key studySeptember 7, 2025 | msn.comAstraZeneca announces Rs 176 crore investment to expand Global Innovation & Technology Centre in ChennaiSeptember 6, 2025 | msn.comAstraZeneca Announces Current Share Capital and Voting RightsSeptember 6, 2025 | theglobeandmail.comAstraZeneca's (LON:AZN) investors will be pleased with their notable 61% return over the last five yearsSeptember 6, 2025 | finance.yahoo.comBerenberg Bank Keeps Their Buy Rating on AstraZeneca (AZN)September 2, 2025 | theglobeandmail.comAstraZeneca’s baxdrostat shows promise in Phase III hypertension trialSeptember 1, 2025 | finance.yahoo.comAstraZeneca bounces back from scandal in ChinaAugust 27, 2025 | ft.comAstraZeneca to build pharma innovation hub in PhilippinesAugust 26, 2025 | msn.comDaiichi Sankyo and AstraZeneca’s Datroway receives approval in ChinaAugust 25, 2025 | msn.comAstraZeneca’s New Asthma Study: Potential Market ImpactAugust 22, 2025 | msn.comAstraZeneca’s Innovative Lung Cancer Screening Study: A Game Changer for Early DetectionAugust 22, 2025 | msn.comAstraZeneca (LSE:AZN) Joins Forces To Launch Sovereign AI Supercomputer With Sferical AIAugust 22, 2025 | finance.yahoo.comAstraZeneca Vietnam office in Hanoi receives LEED Gold certificationAugust 22, 2025 | msn.comPEZA, AstraZeneca partner to boost pharma investments in PHAugust 21, 2025 | msn.comDTI, AstraZeneca to develop Pharma Innovation HubAugust 20, 2025 | msn.comAstraZeneca to build Philippines’ first pharma innovation hubAugust 19, 2025 | msn.comScared of needles? AstraZeneca launches FluMist Home nasal spray deliveryAugust 17, 2025 | msn.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZNCF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AZNCF Media Mentions By Week AZNCF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZNCF News Sentiment▼0.130.53▲Average Medical News Sentiment AZNCF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZNCF Articles This Week▼126▲AZNCF Articles Average Week Get the Latest News and Ratings for AZNCF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for AstraZeneca and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 4Front Ventures News Today Ainos News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today AVAX Technologies News Today BriaCell Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AZNCF) was last updated on 10/3/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredChina’s message to TrumpPorter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZNCF Stock Alerts